Skip to content

Clinical trials

Withdrawn Phase 1/2 Burkitt Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Phase: Phase 1/2 Status: Withdrawn Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20141
20162
20191
20211
20222
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Alliance for Clinical Trials in Oncology1
Celgene1
Children's Oncology Group1
Fred Hutchinson Cancer Center1
Juventas Cell Therapy Ltd.1
Kevin McNerney1
Kunming Hope of Health Hospital1
Masonic Cancer Center, University of Minnesota1
Mayo Clinic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma13
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, Mantle-Cell5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Leukemia, Myeloid, Acute4
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, Follicular4
Lymphoma, Non-Hodgkin4
Leukemia3
Lymphoma3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.